Новиракс-400 400 мг таблетки

Negara: Kirgistan

Bahasa: Rusia

Sumber: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Bahan aktif:

Ацикловир

Tersedia dari:

Oman Pharmaceuticals Products Co., LLC

INN (Nama Internasional):

Acyclovir

Dosis:

400 мг

Bentuk farmasi:

таблетки

Unit dalam paket:

№70

Jenis Resep:

по рецепту

Diproduksi oleh:

Oman Pharmaceuticals Products Co., LLC (Оман)

Ringkasan produk:

ПЖВЛС: нет

Tanggal Otorisasi:

2016-02-15

Karakteristik produk

YTBEP}ITAAIO
JrbHbrr{
Arrper$op
I4H
C
TpyKrII4.fl
rI
O
MEAI4III,I H C
K O
M v rI
P
I4
ME
HE H I,IIO
JI
EKAP
C
T B
E
H H O
f O
CPENCTBA
HOBI4PAKC-4OO
Topronoe
Ha3BaHue
rrperrapara
Honr.rparcc-400
MexaynapoAHoe HerrareHToBaHHoe
Ha3BaHlre
Aqnruoeup
JlenapcrneHHaq
Qopua
Ta6;rerru,400
ur
Cocrae
Olsa ra6lerxa coAep)Kr4T
aKmu*Hoe
seu4ecm6o
*
aIIr.rKJroBup
BP 400 rur,
lcnoMozameJrbHbte
6eulecm6a.'
KyKypy3nrtfi
xpaxual
BP, Harpkrfl
KpaxMan
r.rruxolxr BP,
lpexeJraruHu3upoBaHuuft
xpaxlra,r
BP, MarHI4t
creapar BP.
Onucasue
Belue
rlJrLt
roqrr.r 6elue,
ABo.rrKoBbrrryK,'Ibre
ra6lerxn
c
Hace.rKofi
(NM))
c olnofi cropoHbr
H
npocrbre
c
apyrofr
cropoHbl.
@apmaroreparreBTnqecKas
rpyrrrra
llporueoeupycHbre
[penaparbl
nptMoro
4eftcreux.
Hyueosu4bl LI
HyKneorI4AbI.
Koa ATX
J05AB01
Oa
pn'rarco,rornqecKHe
cnofi
crna
@ap.uaxoxuHemuKa
Aqzrclonup
roJrbKo
rracralrHo
a6cop6upyercs
r,r3
Klr[rer{HuKa.
flocle
npveMa
auLIKnoBIzpa
Ka)Krbre 4
\aca
cpeAHsr
MaKcuMaJrbHarr
paBHoBecHaq
KoHIIeHTpauH.t
B rIJIa3Me
(C,n*)
cocraBrrer 3,1
rr,rxuo:rs
(0,7
nrrhr.n), a cpe4ns.fl.
paBHoBecHafl.MvrnvrMaJrbnar
KoHIIeHTpauI4s
B
rJra3Me
(C.in)
-
1,8 urcnaonr
(0,4
rvrxr/l,rn).
llpu
npueue
400
rrar
u
800
Mr
aIIIdKnoBI,Ipa
Ka)KAbre
4
qaca
Cru* cocraBrqer
5,3
uruors
(1,2
rvlxr/vrn) z
8 rtxnro:n
(1,8
rrtrr/nrn)
coorBercrBeHHo,
o
Cniin
-
2,7
MKMoJrb
(0,6
narcr/rvr,r)
u
4
MKMolb
(0.9
vxr/un)
COOTBETCTBCHHO.
Konqeurpauas
arrr,rKnoBr.rpa
B
cnuHHoMosrosofi
xr4AKocra cocraBllser
r'pu6ltuzureJrbHo
50oh ot efo rrra3Meuuofi
xouqeHTpaur4r4.
Aquxlonup
B He3Haqr4Te,rurofi
crerreHrr
cBs3brBaercs
c 6emaN4l{
rIJIa3MbI
KpoBIr
(9-33%).
HOrO
TEXHUKII
HEHIIfl
fleprzo4
nonyBbrBeAeHr4r
auriKnoBr.rpa
-
2,5-3,3.Iaca.
Eomlxafl
qacrb
rlpelapara
BbIBoAIlTcs
loqKaMr4
B
HeH3MeHeHHoM
Br4Ae.
floqequrrfi
KnI4peHc
aIILIKnoBI{pa
3HaqLITenbHo
npeBblluaer
Knr4peHc
KpeaTuHHHa,
rITo
cBI4AeTeJIbcTByeT
o
BbIBeAeHIAIn
aUI4KnOBI4pa
He
ToJIbKo
nocpeAcrBoM
rly6ouxonofi
$ulrrpaquu,
Ho
v
raualrqenoft
ceKpelrfiIr.
OcHoeurnl
uera6oluroM
arlrlKJroBupa
qBnserca
9-rap6oKcI4MeroKcI,I-MerI4JIryaHvIH,
Ha
Aonro
Koroporo
B M